Today: 29 April 2026
Browse Category

TSX:SKE 27 December 2025 - 30 December 2025

Skeena Resources stock rises today as gold rebounds and Eskay Creek decision watch intensifies

Skeena Resources stock rises today as gold rebounds and Eskay Creek decision watch intensifies

Skeena Resources climbed 3.4% to $24.57 in midday New York trading Tuesday, tracking gains in gold and silver after Monday’s sharp drop. About 565,000 shares traded, below average volume. Investors are watching for Federal Reserve minutes and a January consent decision on the Eskay Creek project, after the Tahltan Nation backed an Impact Benefit Agreement this month.
30 December 2025
··
Skeena Resources Limited Stock (NYSE: SKE): Eskay Creek Headlines, Analyst Price Targets, and What to Watch Before Monday’s Open

Skeena Resources Limited Stock (NYSE: SKE): Eskay Creek Headlines, Analyst Price Targets, and What to Watch Before Monday’s Open

Skeena Resources shares closed at $25.42 on Friday, rising on thin post-holiday trading. New reporting highlighted Tahltan Nation’s vote backing an Impact Benefit Agreement for the Eskay Creek project, with $7,250 payments to members and environmental oversight provisions. Some Tahltan members and Alaska advocates voiced concerns over watershed impacts. No new company press releases were issued in the past 48 hours.
28 December 2025
··
Skeena Resources (SKE) Stock: Tahltan Nation IBA Vote, Record Metals Prices, Analyst Targets—and What to Watch Before Monday’s Open

Skeena Resources (SKE) Stock: Tahltan Nation IBA Vote, Record Metals Prices, Analyst Targets—and What to Watch Before Monday’s Open

Skeena Resources shares closed at $25.42 in New York and C$33.43 in Toronto on Friday, up 3.8% in the U.S. session. On December 15, the Tahltan Nation voted to support an Impact Benefit Agreement for Skeena’s Eskay Creek project in British Columbia. A final consent decision from the Tahltan Central Government Board is expected in January. Environmental assessment review remains ongoing.
27 December 2025
·

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
The Dow Jones Industrial Average dropped 320 points, or 0.65%, to 48,821.82 Wednesday afternoon, heading for a fifth straight loss as investors awaited the Federal Reserve’s rate decision and major tech earnings. Brent crude surged 7.14% to $119.20 after reports of a possible extended Iran blockade. Boeing and Goldman Sachs weighed on the Dow, while Amazon rose and Microsoft slipped in midday trading.
General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Go toTop